-
1Academic Journal
المؤلفون: S. S. Rodionova, M. A. Makarov, G. E. Balychev, A. N. Torgashin, С. С. Родионова, М. А. Макаров, Г. Е. Балычев, А. Н. Торгашин
المصدر: Meditsinskiy sovet = Medical Council; № 6 (2023); 282-288 ; Медицинский Совет; № 6 (2023); 282-288 ; 2658-5790 ; 2079-701X
مصطلحات موضوعية: деносумаб, antiresorptive drugs, D-deficiency, hypocalcemia, denosumab, антирезорбтивные препараты, D-дефицит, гипокальциемия
وصف الملف: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/7531/6715; Baker R.P., Squires B., Gargan M.F., Bannister G.C. Total hip arthroplasty and hemiarthroplasty in mobile, independent patients with a displaced intracapsular fracture of the femoral neck. A randomized, controlled trial. J Bone Joint Surg Am. 2006;88(12):2583–2589. https://doi.org/10.2106/JBJS.E.01373.; Blomfeldt R., Törnkvist H., Ericksson K., Söderqvist A., Ponzer S., Tidermark J. A randomised controlled trial comparing bipolar hemiarthroplasty with total hip replacement for displaced intracapsular fractures of the femoral neck in elderly patients. J Bone Joint Surg Br. 2007;89(2):160–165. https://doi.org/10.1302/0301-620X.89B2.18576.; Parker M.J., Gurusamy K.S. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev. 2006;19(3):CD001706. https://doi.org/10.1002/14651858.CD001706.PUB3.; Миронов С.П., Родионова С.С., Дарчия Л.Ю., Максимов А.А., Панов А.А., Солод Э.И. и др. Патологические переломы, осложняющие остеопороз: клинические рекомендации. 2018. Режим доступа: httpss://www.citopriorov.ru/cito/files/Патологические_переломы_осл_остеопороз.pdf.; Kim B.-S., Lim J.-Y., Ha Y.-C. Recent Epidemiology of Hip Fractures in South Korea. Hip Pelvis. 2020;32(3):119. https://doi.org/10.5371/hp.2020.32.3.119.; Jonas K., Nils W., Alexander D., Stefan B., Henning W., Thilo F. The etiology of revision total hip arthroplasty: current trends in a retrospective survey of 3450 cases. Arch Orthop Trauma Surg. 2020;140(9):1265–1273. https://doi.org/10.1007/S00402-020-03514-3.; Beck R.T., Illingworth K.D., Saleh K.J. Review of periprosthetic osteolysis in total joint arthroplasty: an emphasis on host factors and future directions. J Orthop Res. 2012;30(4):541–546. https://doi.org/10.1002/JOR.21554.; Knutsen A.R., Lau N., Longjohn D.B., Ebramzadeh E., Sangiorgio S.N. Periprosthetic femoral bone loss in total hip arthroplasty: Systematic analysis of the effect of stem design. Hip Int. 2017;27(1):26–34. https://doi.org/10.5301/hipint.5000413.; Sköldenberg O.G., Salemyr M.O., Bodén H.S., Ahl T.E., Adolphson P.Y. The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2011;93(20):1857–1864. https://doi.org/10.2106/JBJS.J.01646.; Friedl G., Radl R., Stihsen C., Rehak P., Aigner R., Windhager R. The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty: A randomized, double-blind, controlled trial. J Bone Joint Surg Am. 2009;91(2):274–281. https://doi.org/10.2106/JBJS.G.01193.; Chen X., Shen Y., Ye C., Mumingjiang Y., Lu J., Yu Y. Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: A network meta-analysis of randomised controlled studies. Postgrad Med J. 2021;97(1145):150–155. https://doi.org/10.1136/postgradmedj-2019-137120.; Ledin H., Good L., Aspenberg P. Denosumab reduces early migration in total knee replacement: A randomized controlled trial involving 50 patients. Acta Orthop. 2017;88(3):255–258. https://doi.org/10.1080/17453674.2017.1300746.; Mahatma M.M., Jayasuriya R.L., Hughes D., Hoggard N., Buckley S.C., Gordon A., et al. Effect of denosumab on osteolytic lesion activity after total hip arthroplasty: a single-centre, randomised, double-blind, placebocontrolled, proof of concept trial. Lancet Publishing Group. 2021;3(3): e195–e203. https://doi.org/10.1016/S2665-9913(20)30394-5.; Белая Ж.Е., Белова К.Ю., Бирюкова Е.В., Дедов И.И., Дзеранова Л.К., Драпкина О.М. и др. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза. Остеопороз и остеопатии. 2021;24(2):4–47. https://doi.org/10.14341/OSTEO12930.; Mjöberg B. Hip prosthetic loosening: A very personal review. World J Orthop. 2021;12(9):629–639. https://doi.org/10.5312/wjo.v12.i9.629.; Campbell D., Mercer G., Nilsson K.G., Wells V., Field J.R., Callary S.A. Early migration characteristics of a hydroxyapatite-coated femoral stem: An RSA study. Int Orthop. 2011;35(4):483–488. https://doi.org/10.1007/s00264-009-0913-z.; Lee S.W., Kim W.Y., Song J.H., Kim J.H., Lee H.H. Factors affecting periprosthetic bone loss after hip arthroplasty. Hip Pelvis. 2021;33(2):53–61. https://doi.org/10.5371/HP.2021.33.2.53.; Johanson P.E., Antonsson M., Shareghi B., Kärrholm J. Early Subsidence Predicts Failure of a Cemented Femoral Stem With Minor Design Changes. Clin Orthop Relat Res. 2016;474(10):2221–2229. https://doi.org/10.1007/s11999-016-4884-2.; Fender D., van der Meulen J.H.P., Gregg P.J. Relationship between outcome and annual surgical experience for the Charnley total hip replacement. J Bone Joint Surg Br. 2003;85(2):187–190. https://doi.org/10.1302/0301-620X.85B2.12759.; Snorrason F., Kärrholm J., Holmgren C. Fixation of cemented acetabular prostheses. The influence of preoperative diagnosis. J Arthroplasty. 1993;8(1):83–90. https://doi.org/10.1016/s0883-5403(06)80112-9.; Sköldenberg O.G., Salemyr M.O., Bodén H.S., Lundberg A., Ahl T.E., Adolphson P.Y. A new uncemented hydroxyapatite-coated femoral component for the treatment of femoral neck fractures: Two-year radiostereometric and bone densitometric evaluation in 50 hips. J Bone Joint Surg Br. 2011;93(5):665–677. https://doi.org/10.1302/0301-620X.93B5.25374.; Aro H.T., Alm J.J., Moritz N., Mäkinen T.J., Lankinen P. Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: A 2-year RSA study of 39 patients. Acta Orthop. 2012;83(2):107–114. https://doi.org/10.3109/17453674.2012.678798.; Szulc P., Seeman E., Duboeuf F., Sornay-Rendu E., Delmas P.D. Bone fragility: Failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res. 2006;21(12):1856–1863. https://doi.org/10.1359/jbmr.060904.; Zebaze R.M., Ghasem-Zadeh A., Bohte A., Iuliano-Burns S., Mirams M., Price R.I., et al. Intracortical remodelling and porosity in the distal radius and postmortem femurs of women: a cross-sectional study. Lancet. 2010;375(9727):1729–1736. https://doi.org/10.1016/S0140-6736(10)60320-0.; Arabmotlagh M., Rittmeister M., Hennings T. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: Prospective randomized double-blind study. J Orthop Res. 2006;24(7):1336–1341. https://doi.org/10.1002/jor.20162.; Seeman E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int. 2003;14(3):2–8. https://doi.org/10.1007/s00198-002-1340-9.; Kärrholm J. Radiostereometric analysis of early implant migration – A valuable tool to ensure proper introduction of new implants. Acta Orthop, 2012;83(6):551–552. https://doi.org/10.3109/17453674.2012.745352.; Aro H.T., Nazari-Farsani S., Vuopio M., Löyttyniemi E., Mattila K. Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty. JBMR Plus. 2019;3(10):e10217. https://doi.org/10.1002/jbm4.10217.; https://www.med-sovet.pro/jour/article/view/7531